NewsView printer-friendly version
Coherus BioSciences Management to Present at the 39th Annual J.P. Morgan Healthcare Conference
The audio portion of the Company presentation will be available on the investors page of the
Coherus is a leading commercial-stage biosimilar company dedicated to expanding access to high-quality therapeutics that can have a major impact on patients’ lives and to delivering significant savings to the health care system. For additional information, please visit www.coherus.com.
McDavid StilwellEVP, Corporate Development, IR and Financial Strategy Coherus BioSciences, Inc.email@example.com +1 (650) 395-0152
Source: Coherus BioSciences, Inc.